蛋白酶激活受体1在囊性纤维化病原体中的作用
Sohinee Sarkar1,2, Jia-Xi Han3, Kristy Azzopardi3
1Murdoch Children's Research Institute, Parkville, Victoria, Australia sohinee.sarkar@mcri.edu.au.
BMJ open respiratory research
|January 20, 2025
概括
蛋白酶激活受体1 (PAR1) 通过影响干白素-6 (IL-6) 水平,有助于囊性纤维化 (CF) 中的肠道病理. 这一发现表明PAR1是CF相关肠道疾病的潜在治疗点.
科学领域:
- 胃肠病学 胃肠病学
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 囊性纤维化 (CF) 通常导致呼吸衰竭.
- 在CF中,炎症和感染驱动肺损伤.
- 蛋白酶激活受体1 (PAR1) 在CF病变发生过程中的作用尚不清楚.
研究的目的:
- 研究PAR1在CF肠道病理中的作用.
- 为了确定PAR1是否影响CF模型中的炎症标志物.
主要方法:
- 产生了缺乏PAR1和CFTR的双重淘汰 (DKO) 鼠标.
- 将DKO小鼠与单个突变物和野生型 (WT) littermates进行比较.
- 监测体重,检查肺部和肠道组织.
主要成果:
- 缺少CFTR的小鼠体重增加较慢,没有肺炎,但胆管和靠近结肠的体重增加.
- DKO小鼠的体重增加与CFTR缺乏的小鼠相似,但仅在近端结肠.
- 在CFTR缺乏的小鼠中,皮质体重增加与增加的IN-6 (IL-6) 水平相关,而在DKO小鼠中没有这种水平.
结论:
- 在CF中,PAR1有助于肠道病理.
- 在CF病变发生过程中,PAR1可能调节IL-6.
- PAR1是CF相关肠道并发症的潜在治疗标.
相关概念视频
Cystic Fibrosis: Pathogenesis
184
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
184
Cystic Fibrosis: Management
139
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
139
GPCRs Regulate Adenylyl Cylase Activity
5.2K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.2K
Caspases
12.2K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
12.2K
The Proteasome
807
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
807
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K


